These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19388879)

  • 41. [Primary hepatocarcinoma treated by traditional Chinese medicine combined with transcatheter arterial chemoembolization].
    Hou EC; Lu YX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Mar; 29(3):225-7. PubMed ID: 19548439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kanglaite injection combined with hepatic arterial intervention for unresectable hepatocellular carcinoma: a meta-analysis.
    Fu F; Wan Y; ; Wu T
    J Cancer Res Ther; 2014 Aug; 10 Suppl 1():38-41. PubMed ID: 25207889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.
    Chia-Hsien Cheng J; Chuang VP; Cheng SH; Lin YM; Cheng TI; Yang PS; Jian JJ; You DL; Horng CF; Huang AT
    Int J Cancer; 2001 Aug; 96(4):243-52. PubMed ID: 11474499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
    Zhang X; Wang K; Wang M; Yang G; Ye X; Wu M; Cheng S
    Oncotarget; 2017 Apr; 8(17):29416-29427. PubMed ID: 28177886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 46. Jian Pi Li Qi Decoction Alleviated Postembolization Syndrome Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Xu L; Wang S; Zhuang L; Lin J; Chen H; Zhu X; Bei W; Zhao Q; Wu H; Meng Z
    Integr Cancer Ther; 2016 Sep; 15(3):349-57. PubMed ID: 26590124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.
    Lobo L; Yakoub D; Picado O; Ripat C; Pendola F; Sharma R; ElTawil R; Kwon D; Venkat S; Portelance L; Yechieli R
    Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1580-1588. PubMed ID: 27586657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.
    Tan X; Xie P; Liu J; Wu H; Xie Y
    Asia Pac J Clin Oncol; 2015 Sep; 11(3):e6-e12. PubMed ID: 25228074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sorafenib in combination with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis.
    Hu MD; Jia LH; Liu HB; Zhang KH; Guo GH
    Eur Rev Med Pharmacol Sci; 2016; 20(1):64-74. PubMed ID: 26813455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma.
    Huang YK; Yen CL; Shiu SI; Lee SW; Chang PY; Yeh HZ; Lee TY
    PLoS One; 2017; 12(11):e0188999. PubMed ID: 29190692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carboplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Yamashita F; Tanaka M; Andou E; Yutani S; Kato O; Tanikawa K
    Oncology; 1997; 54(1):28-33. PubMed ID: 8978589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhu ZX; Wang XX; Yuan KF; Huang JW; Zeng Y
    HPB (Oxford); 2018 Sep; 20(9):795-802. PubMed ID: 29779970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas.
    Zuo TY; Liu FY; Wang MQ; Chen XX
    Chin Med J (Engl); 2017 Nov; 130(22):2666-2673. PubMed ID: 29133753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lobaplatin-TACE combined with radioactive 125I seed implantation for treatment of primary hepatocellular carcinoma.
    Peng S; Yang QX; Zhang T; Lu MJ; Yang G; Liu ZY; Zhang R; Zhang FJ
    Asian Pac J Cancer Prev; 2014; 15(13):5155-60. PubMed ID: 25040967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma.
    Paik EK; Kim MS; Jang WI; Seo YS; Cho CK; Yoo HJ; Han CJ; Park SC; Kim SB; Kim YH
    Radiat Oncol; 2016 Feb; 11():22. PubMed ID: 26896371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis.
    Leng JJ; Xu YZ; Dong JH
    ANZ J Surg; 2016 Oct; 86(10):816-820. PubMed ID: 25088384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug effect analysis of sorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma.
    Xu X; Meng Q
    Pak J Pharm Sci; 2018 Jul; 31(4(Special)):1751-1755. PubMed ID: 30203774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
    Sahara S; Kawai N; Sato M; Tanaka T; Ikoma A; Nakata K; Sanda H; Minamiguchi H; Nakai M; Shirai S; Sonomura T
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1363-71. PubMed ID: 22358993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis.
    Wang WD; Zhang LH; Ni JY; Jiang XY; Chen D; Chen YT; Sun HL; Luo JH; Xu LF
    Korean J Radiol; 2018; 19(4):613-622. PubMed ID: 29962868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.